These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22041176)

  • 1. [Influence of age on antibody titers following rabies post-exposure prophylaxis].
    Gautret P; Vu Hai V; Soavi MJ; Parola P; Brouqui P
    Pathol Biol (Paris); 2012 Oct; 60(5):322-3. PubMed ID: 22041176
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case-control study on the effect of immunoprophylaxis for rabies in Zhejiang province].
    Gong ZY; He F
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Feb; 45(2):123-6. PubMed ID: 21426790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.
    Quiambao BP; Dy-Tioco HZ; Dizon RM; Crisostomo ME; Teuwen DE
    Vaccine; 2009 Nov; 27(51):7162-6. PubMed ID: 19925947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.
    Tenzin ; Dhand NK; Ward MP
    Vaccine; 2011 May; 29(24):4094-101. PubMed ID: 21497633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
    Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
    Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies post-exposure prophylaxis in travellers returning from Bali, Indonesia, November 2008 to March 2010.
    Gautret P; Lim PL; Shaw M; Leder K
    Clin Microbiol Infect; 2011 Mar; 17(3):445-7. PubMed ID: 20491825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India.
    J TM; Mathew T; S AT; M SC; Philip RR
    Natl Med J India; 2012; 25(5):268-70. PubMed ID: 23448625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic status is a critical risk factor for human rabies post-exposure prophylaxis.
    Fang LX; Ping F; Ping du Y; Hui BG; Yan YX
    Vaccine; 2010 Oct; 28(42):6847-51. PubMed ID: 20723628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure anti-rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2006-2011.
    Krzowska-Firych J; Tomasiewicz K; Sukhadia T; Wierzchowska-Opoka M; Khoury S
    Ann Agric Environ Med; 2012; 19(2):275-8. PubMed ID: 22742801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment antibody titers in repeated rabies prophylaxis.
    Lutwick LI; Shanley JD
    JAMA; 1980 Aug; 244(7):691. PubMed ID: 7392170
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.
    Wang LY; Sun MP; Zhang XC; Suo LD; Xu RH; Zou YJ; Zuo LB; Qi H
    Vaccine; 2011 Mar; 29(15):2679-81. PubMed ID: 21296694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations.
    Uwanyiligira M; Landry P; Genton B; de Valliere S
    Clin Infect Dis; 2012 Jul; 55(2):201-5. PubMed ID: 22550115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for human rabies in China.
    Gong Z; He F; Chen Z
    Zoonoses Public Health; 2012 Feb; 59(1):39-43. PubMed ID: 21824368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Currently approved post-exposure rabies prophylaxis regimens.
    Wilde H; Wacharapluesadee S; Hemachudha T
    Travel Med Infect Dis; 2012 May; 10(3):162-3. PubMed ID: 22578883
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies post-exposure prophylaxis.
    Weinstein S
    J Ark Med Soc; 2013 Sep; 110(4):60-1. PubMed ID: 24079054
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations.
    Shantavasinkul P; Tantawichien T; Wacharapluesadee S; Jeamanukoolkit A; Udomchaisakul P; Chattranukulchai P; Wongsaroj P; Khawplod P; Wilde H; Hemachudha T
    Clin Infect Dis; 2010 Jan; 50(1):77-9. PubMed ID: 19995214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.